Literature DB >> 23188507

A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task Force.

Stephan Beck1, Bradley E Bernstein, Robert M Campbell, Joseph F Costello, Dashyant Dhanak, Joseph R Ecker, John M Greally, Jean-Pierre Issa, Peter W Laird, Kornelia Polyak, Benjamin Tycko, Peter A Jones.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23188507     DOI: 10.1158/0008-5472.CAN-12-3658

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

Review 1.  Mapping human epigenomes.

Authors:  Chloe M Rivera; Bing Ren
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

Review 2.  Targeting the cancer epigenome for therapy.

Authors:  Peter A Jones; Jean-Pierre J Issa; Stephen Baylin
Journal:  Nat Rev Genet       Date:  2016-09-15       Impact factor: 53.242

3.  Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.

Authors:  Lijing Yao; Hui Shen; Peter W Laird; Peggy J Farnham; Benjamin P Berman
Journal:  Genome Biol       Date:  2015-05-21       Impact factor: 13.583

Review 4.  Genome-wide epigenomic profiling for biomarker discovery.

Authors:  René A M Dirks; Hendrik G Stunnenberg; Hendrik Marks
Journal:  Clin Epigenetics       Date:  2016-11-21       Impact factor: 6.551

Review 5.  Epigenetic Alterations in Parathyroid Cancers.

Authors:  Chiara Verdelli; Sabrina Corbetta
Journal:  Int J Mol Sci       Date:  2017-02-01       Impact factor: 5.923

Review 6.  Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling.

Authors:  Feng Liu; Paul S Mischel; Webster K Cavenee
Journal:  NPJ Precis Oncol       Date:  2017-03-20

Review 7.  Chromatin regulatory mechanisms and therapeutic opportunities in cancer.

Authors:  Alfredo M Valencia; Cigall Kadoch
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

8.  A strategy to identify dominant point mutant modifiers of a quantitative trait.

Authors:  William F Dove; Alexandra Shedlovsky; Linda Clipson; James M Amos-Landgraf; Richard B Halberg; Kathleen J Krentz; Frederick J Boehm; Michael A Newton; David J Adams; Thomas M Keane
Journal:  G3 (Bethesda)       Date:  2014-04-17       Impact factor: 3.154

9.  Synergy and competition between cancer genome sequencing and epigenome mapping projects.

Authors:  Christoph Bock
Journal:  Genome Med       Date:  2014-05-30       Impact factor: 11.117

Review 10.  Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancers.

Authors:  Mariko Sasaki; Hideaki Ogiwara
Journal:  Cancer Sci       Date:  2020-02-22       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.